Incidence of side-effects of ticlopidine after sirolimus-eluting stent implantation - Retrospective analysis from three hospitals

Circulation Journal

Volumn 71, Issue 4, 2007, Pages 617-619

  Fukushima, Kenichi ^a   Kobayashi, Yoshio ^a   Okuno, Tomonobu ^b   Nakamura, Yoshitake ^c   Sakakibara, Masayoshi ^b   Nakayama, Takashi ^a   Kuroda, Nakabumi ^a   Miyazaki, Akira ^c   Shimizu, Youichi ^b   Komuro, Issei ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Shin Katsushika Hospital   (Japan)

^c Chiba Cardiovascular Center   (Japan)

Author keywords

Antiplatelet therapy; Stent; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ARTICLE; BLEEDING; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DRUG ELUTING STENT; DRUG FATALITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE ORGAN FAILURE; NEUTROPENIA; RASH; RETROSPECTIVE STUDY; SEPSIS; THROMBOCYTOPENIA; THROMBOSIS; URTICARIA;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY THROMBOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; DRUG TOXICITY; EXANTHEMA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; JAPAN; LIVER DISEASES; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; TICLOPIDINE;

EID: 34047098340     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.617     Document Type: Article

References (9)

1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
2. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 2088-2092.
3. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006; 113: 1108-1113.
4. Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 2006; 98: 352-356.
5. Ishikawa T, Mutoh M, Fuda Y, Sakamoto H, Okada H, Higashitani M, et al. Documented subacute stent thrombosis within thirty days after stenting with sirolimus-eluting stent (Cypher) for acute myocardial infarction. Circ J 2006; 70: 1091-1092.
6. Gaku N, Kengo T, Aoki J, Onuma Y, Yamamoto H, Higashikuni Y, et al. Clinical and angiographic outcomes of sirolimus-eluting stents implantation in Japanese patients in daily practice. Circ J 2006; 70: 1367-1371.
7. Moussa I, Oetgen M, Roubin G, Colombo A, Wang X, Iyer S, et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 1999; 99: 2364-2366.
8. Takeyasu N, Watanabe S, Noguchi Y, Ishikawa K, Fumikura Y, Yamaguchi I. Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting. Circ J 2005; 69: 780-785.
9. Sekiguchi M, Hoshizaki H, Adachi H, Ohshima S, Taniguchi K, Kurabayashi M. Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: A randomized comparison of ticlopidine and cilostazol. Circ J 2004; 68: 610-614.